Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2
Abstract Background Non-pharmaceutical measures to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) should be carefully tuned as they can impose a heavy social and economic burden. To quantify and possibly tune the efficacy of these anti-SARS-CoV-2 measures, we have...
Saved in:
Main Authors: | Simo Kitanovski (Author), Gibran Horemheb-Rubio (Author), Ortwin Adams (Author), Barbara Gärtner (Author), Thomas Lengauer (Author), Daniel Hoffmann (Author), Rolf Kaiser (Author), Respiratory Virus Network (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Respiratory viruses dynamics and interactions: ten years of surveillance in central Europe
by: Gibran Horemheb-Rubio, et al.
Published: (2022) -
Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2
by: Laxmikant Wali, et al.
Published: (2022) -
Rhabdomyolysis Caused by Rhinovirus
by: Lay Ong Tan MB BCH BAO, DCH, MMED (Paed), et al.
Published: (2016) -
NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION
by: Barbara Faganel Kotnik, et al.
Published: (2021) -
Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies
by: Kak-Ming Ling, et al.
Published: (2018)